Beattie Nell

Avg. Two Year Performance

11% Avg. Purchase Return

5% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	5%	22%	16%	109%	11%
Purchase Success Rate	3 of 4	1 of 4	2 of 4	2 of 4	1 of 4
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Vbi Vaccines Inc/bc

Drugs » Biotechnology

CFO, Head of Corp. Development, Director:

Holdings: 68.2K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--